Icon Interventional Systems Inc is categorized under Commercial Medical Research in Atlanta, GA and active since 2003.
Icon Interventional Systems Inc was established in 2003, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Jack Merritt at the company’s single location by writing to 387 Technology Circle Nw # 500, Atlanta, Georgia GA 30313 or by phoning (678) 651-2319. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Icon Interventional Systems Inc |
| Contact Person: | Jack Merritt |
| Address: | 387 Technology Circle Nw # 500, Atlanta, Georgia 30313 |
| Phone Number: | (678) 651-2319 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Icon Interventional Systems Inc was started in 2003 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Jack Merritt for inquiries that concern Icon Interventional Systems Inc by calling the company number (678) 651-2319, as your correspondence is most welcome. Additionally, the physical location of the single location of Icon Interventional Systems Inc can be found at the coordinates 33.768908,-84.401636 as well as the street address 387 Technology Circle Nw # 500 in Atlanta, Georgia 30313.
For its online presence, you may visit Icon Interventional Systems Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.